01 / FAST-MELT MATRIX
Sub-30 Second Disintegration
Formulated with specialized croscarmellose and microcrystalline matrices that dissolve seamlessly on the tongue within 30 seconds, enabling fast mucosal uptake without swallowing discomfort.
Blessme · Anti-Panic & Anxiolytics
Clonazepam MD Tablets - DELOTRIL (0.5 mg)
DELOTRIL-0.5 is a fast-melt Clonazepam Mouth Dissolving Tablets IP 0.5 mg formulation by Blessme, the dedicated neuro-psychiatric division of Dellwich Lifescience LLP. Manufactured under strict WHO-GMP compliance, DELOTRIL-0.5 delivers rapid sublingual dissolution and clinical panic relief without requiring water, offering dependable anti-panic and anticonvulsant efficacy for hospitals and PCD franchise partners across India.
Fast-Melt MD Formulation
Schedule H Prescription
Pan-India Supply
Product SpecificationsAbout Clonazepam MD 0.5 mg
About Clonazepam MD 0.5 mg
(DELOTRIL-0.5)
Detailed pharmaceutical specifications, active API monograph compliance, fast-melt characteristics, and packaging details for DELOTRIL-0.5.
Blessme · Anti-Panic / Anticonvulsants
Clonazepam MD 0.5 mg - DELOTRIL
Clonazepam Mouth Dissolving Tablets IP 0.5 mg (DELOTRIL-0.5) is a high-potency benzodiazepine oral formulation engineered to dissolve rapidly on the tongue without water. Provides rapid relief for panic disorder, acute anxiety crises, and seizure maintenance under expert medical supervision.
Fast Mouth-Dissolving Technology (No Water Needed) Primary Clinical Choice in Acute Panic Disorder Standard 0.5 mg Therapeutic Strength Oral Adjunctive Anticonvulsant Therapy Strict Indian Pharmacopoeia Quality Standards
- Product Brand Name
- DELOTRIL-0.5
- Active Pharmaceutical Ingredient
- Clonazepam IP (0.5 mg)Verified IP
- Dosage Formulation
- Mouth Dissolving Tablet (MD / ODT)
- Therapeutic Class
- High-Potency Benzodiazepine / Anti-Panic / Anxiolytic / Anticonvulsant
- Strength
- 0.5 mg per tablet
- Standard Packaging
- 5x4x10 (200 Tablets) Blister Pack
- Regulatory Category
- Schedule H Prescription Drug
- Marketing Division
- Blessme · Neuro & Psychiatric Products
- Marketing & Distribution Company
- Dellwich Lifescience LLP, Ahmedabad, Gujarat
- Storage Condition
- Store protected from light and moisture at a temperature below 25°C
- Quality Standard
- Manufactured in WHO-GMP & ISO 9001:2015 Certified Units
- Country of Origin
- India
Clinical & Commercial MonographClonazepam MD Tablet 0.5 mg & DELOTRIL
Clonazepam MD Tablet 0.5 mg & DELOTRIL
Complete Medical & Supply Guide
Comprehensive clinical and supply guide on Clonazepam Mouth Dissolving Tablets IP 0.5 mg, marketed as DELOTRIL-0.5 by Blessme (Dellwich Lifescience LLP). Covers receptor pharmacology, sublingual kinetics, panic disorder treatment protocols, and B2B pharmaceutical distribution across India.
What is Clonazepam MD Tablet 0.5 mg (DELOTRIL-0.5)?
Clonazepam MD tablet 0.5 mg is the cornerstone therapeutic strength of Clonazepam IP, prepared in an advanced mouth-dissolving tablet format. Upon placement on the tongue, saliva triggers rapid matrix breakdown within 30 seconds, enabling the patient to take the medicine seamlessly without water.
When physicians and pharmacists search for Clonazepam MD tablet, Clonazepam mouth dissolving tablet, or Clonazepam 0.5 mg tablet, they seek consistent bioavailability, rapid onset, and robust packaging. DELOTRIL-0.5 meets these rigorous requirements through automated clean-room compression under WHO-GMP compliance.
Clinical Uses & Indications of Clonazepam MD 0.5 mg
Clonazepam MD tablet uses for the 0.5 mg strength represent essential evidence-based neuropsychiatric indications:
- Panic Disorder & Agoraphobia: Standard therapeutic regimen to prevent and abort acute panic attacks, anticipatory fear, and phobic avoidance.
- Severe Generalized Anxiety Disorder (GAD): Sustained reduction in motor tension, autonomic arousal, and excessive apprehension.
- Epileptic Seizure Maintenance: Oral adjunctive control in absence seizures, myoclonic jerks, and Lennox-Gastaut syndrome.
- Acute Agitation & Akathisia: Prompt calming in neuroleptic-induced motor restlessness and acute psychiatric distress.
- Social Anxiety Disorder: Clinically proven reduction in situational panic and severe performance anxiety.
Neurochemical Mechanism of Action & Sublingual Dynamics
Clonazepam 0.5 mg acts as a potent positive allosteric modulator on the GABAA receptor-chloride ion channel complex. By increasing the frequency of channel openings in response to gamma-aminobutyric acid, it stimulates significant chloride influx into post-synaptic neurons.
The resultant hyperpolarization stabilizes neuronal membranes throughout the amygdala and fear-processing neural circuits. With DELOTRIL-0.5's mouth-dissolving delivery, direct buccal and sublingual mucosal absorption facilitates rapid therapeutic blood levels, delivering faster relief during acute panic episodes than standard gastrointestinal absorption.
Strength Comparison: DELOTRIL-0.25 vs. DELOTRIL-0.5
Clinical rationale for choosing between the two strengths:
- DELOTRIL-0.25 (0.25 mg): Starting micro-dose for initial acclimatization, mild situational anxiety, and geriatric patients prone to daytime sedation.
- DELOTRIL-0.5 (0.5 mg): The standard clinical maintenance dose for established panic disorder, severe acute anxiety attacks, and seizure prophylaxis.
- Clinical Flexibility: Allows exact titration from 0.25 mg up to 0.5 mg or 1 mg daily as determined by the treating specialist.
Dosage Guidelines & Administration Method
DELOTRIL-0.5 must be taken in accordance with medical prescription:
- Administration: Place the tablet on the tongue until it dissolves completely in saliva, then swallow. No water is needed.
- Panic Disorder Dose: Usually 0.25 mg to 0.5 mg twice daily, with a maximum target dose of 1 mg daily in most patients.
- Seizure Maintenance: Initial adult dose of 1.5 mg daily divided into three doses, titrated upwards as needed.
- Gradual Discontinuation: Taper slowly by 0.125 mg to 0.25 mg every 3 days under medical supervision.
Clonazepam MD Tablet Brands in India & DELOTRIL Advantage
Among popular brands in India (Clonafit, Zapiz, Epitril), DELOTRIL-0.5 by Blessme is recognized for exceptional reliability and commercial value:
- Instant Salivary Disintegration: Melts completely within 30 seconds with a pleasant oral feel.
- Moisture-Proof Blister Packing: 5x4x10 foil blister strip prevents moisture ingress in tropical conditions.
- Direct Manufacturer Pricing: High profit margins with district-wise monopoly PCD franchise rights.
- Full Regulatory Dossiers: Authenticated COA, MSDS, and stability records provided with every batch.
Side Effects, Precautions & Patient Safety
Essential clinical warnings for healthcare professionals and patients:
- Expected Reactions: Drowsiness, fatigue, lightheadedness, and temporary impairment of motor coordination.
- Avoid Concurrent Depressants: Never combine with alcohol, opioids, or sedatives due to lethal respiratory suppression risks.
- Dependence Risk: Long-term continuous use can induce physical and psychological dependence; keep therapy duration to the minimum necessary.
- Contraindications: Severe respiratory insufficiency, myasthenia gravis, and severe liver failure.
Critical Safety Warning - Schedule H Controlled Psychotropic Substance
Clonazepam is a potent benzodiazepine with significant potential for habit formation, tolerance, and physical dependence. Long-term use should be carefully monitored. DELOTRIL-0.5 is supplied strictly against a valid medical prescription from a registered medical practitioner.
Quality & Production
Pharmaceutical Quality Assurance & Compliance
DELOTRIL-0.5 is manufactured in advanced automated pharmaceutical facilities adhering to WHO-GMP, ISO 9001:2015, and Schedule M standards, ensuring exceptional fast-melt uniformity and batch-to-batch consistency.
02 / HIGH-BARRIER FOIL
Moisture-Proof Blister Sealing
Encased in 5x4x10 protective blister cavities that insulate the hygroscopic fast-melt tablet from ambient atmospheric moisture, heat, and physical crumbling.
03 / ANALYTICAL TESTING
COA & Content Uniformity
Strict pharmacopoeial monograph assays confirm precise 0.5 mg Clonazepam IP content, rapid disintegration limits, and dissolution conformity batch after batch.
04 / PRODUCTION STANDARDS
WHO-GMP & Schedule M
Produced in state-of-the-art clean-room compression suites adhering to WHO-GMP, ISO 9001:2015, and Good Laboratory Practices (GLP) with automated environmental controls.
Clinical Profile & Precautions
Approved Indications & Regulatory Guidelines
As a Schedule H controlled benzodiazepine medication, Clonazepam MD requires responsible clinical oversight, patient counseling, and adherence to prescription mandates.
Prescription-Only Schedule H Medication Notice
DELOTRIL-0.5 contains Clonazepam IP 0.5 mg. To be sold by retail on the prescription of a Registered Medical Practitioner only. Do not exceed prescribed duration. Caution is advised when driving motor vehicles or handling complex machinery.
Clinical Indications Profile
Approved neurological and psychiatric indications for Clonazepam MD 0.5 mg (DELOTRIL-0.5):
- Panic Disorder & Agoraphobia: Standard therapeutic regimen for acute panic termination and long-term prevention.
- Generalized Anxiety Disorder: Daytime tranquilization and reduction of somatic anxiety tension.
- Epileptic Seizure Management: Oral adjunctive therapy for myoclonic, absence, and refractory seizures.
- Social Phobia & Performance Anxiety: Rapid-onset alleviation of acute situational panic.
- Akathisia & Motor Restlessness: Symptomatic control in drug-induced extrapyramidal restlessness.
Pharmacology & Clinical Precautions
Key pharmacokinetic parameters and patient monitoring guidelines:
- Mechanism: High-affinity positive allosteric modulation of GABA_A chloride channel conductance.
- Synergistic Depression: Severe respiratory risk if co-administered with alcohol, opioids, or sedatives.
- Hepatic Clearance: Extensively metabolized in the liver to 7-amino-clonazepam; dose reduction is advised in hepatic dysfunction.
- Pregnancy Category D: Potential risks of fetal harm; avoid during pregnancy and lactation unless strictly essential.
Manufacturing & Marketing
Dellwich Lifescience LLPBlessme · Neuro & Psychiatric Division
About Dellwich Lifescience
Trusted Neuro & Psychiatric Pharmaceutical Manufacturer in Ahmedabad, Gujarat
Dellwich Lifescience LLP is an established pharmaceutical company based in Science City, Ahmedabad, Gujarat, dedicated to advanced formulation technology, uncompromising quality assurance, and ethical healthcare supply. Through our specialized neurology division, Blessme, we manufacture and market superior neuro-psychiatric treatments, including DELOTRIL-0.5 (Clonazepam MD Tablets IP 0.5 mg).
We support PCD pharma franchise partners, hospital supply chains, and contract manufacturing clients across India with guaranteed supply security, validated product dossiers, and prompt dispatch.
Commercial PartnershipsDELOTRIL-0.5 Supply &
DELOTRIL-0.5 Supply &
Pharmaceutical Distribution
Whether you are seeking DELOTRIL-0.5 (Clonazepam MD Tablets IP 0.5 mg) for district monopoly PCD franchise distribution, third-party contract manufacturing, or hospital bulk procurement, Dellwich Lifescience LLP delivers dependable supply and competitive trade margins.
Monopoly PCD Franchise
Secure exclusive district-level distribution rights for DELOTRIL-0.5 and the entire Blessme Neuro portfolio with promotional visual aids, doctor samples, and attractive trade margins.
Third-Party Manufacturing
Contract manufacturing solutions for Clonazepam MD tablets (0.25 mg, 0.5 mg, 1 mg, 2 mg) with custom batch sizing, stability dossier preparation, and fast delivery timelines.
Hospital & Institutional Supply
Direct supply partnerships for psychiatric hospitals, neuropsychiatric clinics, de-addiction centers, and state government health tenders across India.
Blessme · DELOTRIL-0.5
Why Choose DELOTRIL-0.5 (Clonazepam MD 0.5 mg)?
When sourcing Clonazepam MD tablets IP or evaluating dependable clonazepam mouth dissolving tablet brands in India, DELOTRIL-0.5 by Blessme provides exceptional quality, rapid disintegration, and comprehensive B2B support.
WHO-GMP Certified Purity
Manufactured in WHO-GMP and ISO 9001:2015 certified units using pharmacopoeial grade Clonazepam IP, guaranteeing assay precision and fast-melt integrity.
High-Barrier Blister Packaging
Tamper-evident, moisture-resistant 5x4x10 blister strips protect fragile mouth-dissolving tablets from ambient humidity and transit friction.
Pan-India Dispatch from Ahmedabad
Direct factory dispatch from Science City, Ahmedabad with GST invoicing, verified batch COA, and dependable logistics coverage across all Indian states.
Monopoly PCD Franchise Rights
Exclusive district-level franchise rights for DELOTRIL-0.5 and the entire Blessme Neuro portfolio with promotional tools, visual aids, and MR bags.
Comprehensive Regulatory Dossiers
Certificates of Analysis (COA), stability testing data, and Material Safety Data Sheets (MSDS) readily available for institutional tenders and hospital audits.
Direct Manufacturer Support
Direct access to Dellwich Lifescience LLP product specialists for quick quotes, customized bulk supply inquiries, and dedicated customer assistance.
Common Questions
Frequently Asked Questions about DELOTRIL-0.5
Authoritative answers to clinical, commercial, dosage, and regulatory questions regarding Clonazepam MD Tablets IP 0.5 mg.
What is Clonazepam MD tablet 0.5 mg and what is DELOTRIL-0.5?
Clonazepam MD tablet 0.5 mg (marketed under the brand name DELOTRIL-0.5 by Blessme division of Dellwich Lifescience LLP) is an advanced orally disintegrating benzodiazepine formulation. Each tablet contains Clonazepam IP 0.5 mg, engineered to rapidly dissolve on the tongue without water for quick sublingual and pre-gastric absorption, effectively terminating acute panic attacks, severe anxiety, and seizure episodes.
How does the Mouth Dissolving (MD) technology in DELOTRIL-0.5 benefit patients?
Mouth Dissolving technology enables DELOTRIL-0.5 to melt completely in the oral cavity within 30 seconds upon contact with saliva. Patients experiencing sudden panic or choking sensations during acute anxiety do not need water to take their medication. A portion of the active Clonazepam is rapidly absorbed across the rich vascular beds of the sublingual mucosa, ensuring a faster clinical onset.
What are the primary clinical indications of Clonazepam MD 0.5 mg?
Clonazepam MD 0.5 mg (DELOTRIL-0.5) is clinically prescribed for: (1) acute and maintenance treatment of panic disorder with or without agoraphobia; (2) generalized anxiety disorder (GAD) and severe situational phobia; (3) maintenance oral therapy in epileptic seizure disorders, including absence seizures, myoclonic jerks, and Lennox-Gastaut syndrome; and (4) acute symptomatic management of akathisia and restless legs syndrome.
What is the difference between DELOTRIL-0.25 and DELOTRIL-0.5?
DELOTRIL-0.25 contains 0.25 mg Clonazepam IP, primarily utilized for initial therapy initiation, mild-to-moderate situational anxiety, and sensitive or geriatric patients to avoid morning grogginess. DELOTRIL-0.5 contains 0.5 mg Clonazepam IP, representing the standard therapeutic clinical dose for managing established panic disorder, severe acute anxiety crises, and seizure maintenance.
How does Clonazepam 0.5 mg work in the brain (Mechanism of Action)?
Clonazepam acts as a high-potency positive allosteric modulator on GABA_A receptors in the brain. It enhances the binding affinity of the primary inhibitory neurotransmitter GABA, opening chloride channels and causing hyperpolarization of neuronal membranes. This lowers electrical excitability in the amygdala, hippocampus, and cerebral cortex, rapidly dampening panic circuits.
Can DELOTRIL-0.5 be purchased over-the-counter without a prescription?
No. Clonazepam is classified as a Schedule H prescription drug and controlled psychotropic substance in India. DELOTRIL-0.5 can only be dispensed against a valid prescription issued by a registered medical practitioner.
What packaging and strip configurations are available for DELOTRIL-0.5?
DELOTRIL-0.5 is packaged in specialized 5x4x10 blister strips (200 tablets per box) manufactured with moisture-proof barrier foils that protect the delicate fast-melt tablet matrix from atmospheric humidity and transit shock.
Who manufactures and markets DELOTRIL-0.5 in Ahmedabad, India?
DELOTRIL-0.5 is manufactured under WHO-GMP compliance and marketed by Dellwich Lifescience LLP, headquartered in Science City, Ahmedabad, Gujarat, under its dedicated neurology and psychiatry division 'Blessme Neuro Products'.
Is PCD pharma franchise available for DELOTRIL-0.5 across India?
Yes. Dellwich Lifescience LLP provides exclusive district monopoly PCD pharma franchise opportunities for DELOTRIL-0.5 and the entire Blessme Neuro and Psychiatric range, complete with promotional visual aids, LBLs, MR bags, and prompt delivery.
How should DELOTRIL-0.5 be taken, and what is the typical dosage?
Place the tablet directly on the tongue. It dissolves rapidly in saliva and can be swallowed without water. For panic disorder, the typical adult maintenance dose is 0.5 mg to 1 mg per day in divided doses (morning and bedtime). For epilepsy, dosage is titrated individually by the neurologist.
What are the common side effects of Clonazepam MD 0.5 mg tablet?
Common adverse reactions include drowsiness, dizziness, motor fatigue, and mild coordination difficulties. Patients must refrain from driving or operating heavy machinery. Long-term use requires gradual tapering under physician oversight to prevent rebound anxiety.
What is the price of Clonazepam 0.5 mg MD tablet in India?
DELOTRIL-0.5 offers highly competitive pricing with robust commercial margins. For official trade rate lists, PCD franchise terms, and hospital tender quotations, contact Dellwich Lifescience LLP at +91-9909931992 or [email protected].
Does Dellwich Lifescience provide third-party contract manufacturing for Clonazepam MD 0.5 mg?
Yes. Dellwich Lifescience LLP offers third-party and contract manufacturing for Clonazepam MD tablets across 0.25 mg, 0.5 mg, 1 mg, and 2 mg strengths in WHO-GMP certified facilities with complete stability validation.
Does DELOTRIL-0.5 come with an authenticated Certificate of Analysis (COA)?
Yes. Every batch of DELOTRIL-0.5 is accompanied by an authenticated Certificate of Analysis (COA), disintegration test certificates, assay validation, and Material Safety Data Sheet (MSDS).
Direct Pharmaceutical Enquiry
Need Verified Information or Bulk Supply of DELOTRIL-0.5?
Connect directly with Dellwich Lifescience LLP for trade pricing, district monopoly PCD rights, third-party manufacturing, or institutional hospital tender supplies.
Direct Manufacturer Pricing & Transparent MOQ
Exclusive PCD Monopoly Rights for Designated Districts
Fast Dispatch from Ahmedabad with GST Invoicing
Comprehensive Marketing, Visual Aids & Promotional Inputs
Quick Assistance & Orders
Enquire About DELOTRIL-0.5
Get bulk pricing, PCD monopoly availability, and technical documentation for Clonazepam MD 0.5 mg.